Key terms
About ACCD
Accolade, Inc. engages in the provision of technology-enabled health and benefits solutions. The company was founded by Thomas K. Spann, J. Michael Cline, and Sudhir Steven Singh in January 2007 and is headquartered in Seattle, WA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ACCD news
Apr 22
6:33am ET
Accolade price target lowered to $13 from $15 at Stifel
Apr 22
1:31am ET
Analysts Conflicted on These Healthcare Names: SAGE Therapeutics (SAGE), Accolade (ACCD) and Intuitive Surgical (ISRG)
Apr 18
6:10am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Accolade (ACCD), Ultragenyx Pharmaceutical (RARE) and Bristol-Myers Squibb (BMY)
Mar 19
9:04am ET
Accolade promotes Kelsi McDonald Harris to Chief People Officer
Feb 27
5:59am ET
Balancing Potential and Prudence: A Hold Rating for Accolade’s Market Prospects and Financial Strategy
Feb 26
8:25am ET
D.A. Davidson Remains a Hold on Accolade (ACCD)
Feb 26
6:44am ET
Accolade initiated with an Outperform at Leerink
Feb 06
7:48am ET
Stifel Nicolaus Sticks to Their Buy Rating for Accolade (ACCD)
No recent press releases are available for ACCD
ACCD Financials
Key terms
Ad Feedback
ACCD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ACCD Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range